Valeant Pharmaceuticals Intl Inc news

   Watch this stock
Showing stories 1 - 10 of about 140   

Articles published

VRX 223.02 +6.09 (2.81%)
price chart
Valeant Pharmaceuticals International Inc CFO steps down as profit tops ...
Canadian PressValeant Pharmaceuticals International Inc., the Canadian drugmaker known for its serial acquisitions, reported first-quarter profit that topped analysts' estimates and raised its forecast for the year.
Morgan Stanley Reviews Valeant Pharmaceuticals' Earnings  Benzinga
Valeant Announces CFO Succession Plan And Additional Executive Appointment  MarketWatch
Valeant Pharmaceuticals International Inc's bid for Salix Pharmaceuticals ...
Canadian Press//Ryan RemiorzValeant Pharmaceuticals International Inc's chief executive Mike Pearson agreed to buy bowel drug maker Salix Pharmaceuticals Ltd in late February for about US$10 billion, or US$158 all cash offer per share.
Valeant Comments On Endo Offer To Acquire Salix  Canada NewsWire (press release)
Surprise Rival Bid Emerges for Salix  Wall Street Journal
Deal-Making Valeant Pharmaceuticals Intl Inc. Shows No Signs of Slowing Down
The Toronto Stock Exchange is dominated by energy and financial stocks. But over the past few months, one of the best-performing sectors on the TSX has been healthcare, led by Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX), an acquisitive drug ...
Valeant Pharmaceuticals Intl's Buy Rating Reaffirmed at Cantor ...  sleekmoney
Inorganic Growth Becoming Norm For US Pharma As Endo International Loses ...  InvestCorrectly
Analyst Update: Canadian Solar Inc., Ambarella, Inc., and Valeant ...
Analysts are weighing in today on solar panel maker Canadian Solar Inc. (NASDAQ:CSIQ), semiconductor concern Ambarella Inc (NASDAQ:AMBA), and biotech firm Valeant Pharmaceuticals Intl Inc (NYSE:VRX). Here's a quick look at today's brokerage notes ...
TSX pares losses for the week, Valeant Pharmaceuticals heads for record
Canadian stocks rose the most in five weeks as Valeant Pharmaceuticals International Inc. rallied to a record and base metals producers advanced.
CANADA STOCKS-TSX climbs, led by Valeant, materials and banks  Reuters
Valeant Pharmaceuticals Intl Inc (VRX) Releases FY15 Earnings Guidance
Valeant Pharmaceuticals Intl logo Valeant Pharmaceuticals Intl Inc (NYSE:VRX) issued an update on its FY15 earnings guidance on Wednesday morning.
Valeant Pharmaceuticals Intl Inc (NYSE:VRX) a Buy: Cantor Fitzgerald  Markets.co
Will Valeant Pharmaceuticals Intl Inc (VRX) Continue to Pay Off?
Valeant Pharmaceuticals Intl Inc (NYSE:VRX)'s growth began with the acquisition spree initiated in 2008, when its CEO, Michael Pearson, joined.
Large Inflow of Money Witnessed in Valeant Pharmaceuticals International, Inc.  Trade Journo
Pharma Giants Like Valeant Pharmaceuticals Intl Inc Adopt Aggressive New ...
On February 10 this year, Valeant Pharmaceuticals Intl Inc (NYSE:VRX) acquired the rights of two blockbuster heart drugs from Marathon Pharmaceuticals LLC at an undisclosed amount.
Highway Robbery: Patients End Up Paying For the Biotech Bubble  Smarter Analyst
June 12th Options Now Available For Valeant Pharmaceuticals International (VRX)
Investors in Valeant Pharmaceuticals International Valeant Pharmaceuticals International Inc (NYSE: VRX) saw new options become available today, for the June 12th expiration.
Stifel Nicolaus Boosts Valeant Pharmaceuticals Intl Price Target to $250.00 (VRX)
Valeant Pharmaceuticals Intl Inc logo Valeant Pharmaceuticals Intl (NYSE:VRX) had its price target upped by Stifel Nicolaus from $230.00 to $250.00 in a research note issued to investors on Thursday.